NCT01426958 - Investigation of Ritonavir Effects on Afatinib Exposure in Healthy Subjects | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

August 31, 2011

Primary Completion Date

December 31, 2011

Conditions

Healthy

Interventions

DRUG

afatinib

standard therapeutic dose

DRUG

ritonavir + afatinib

simultaneous intake of ritonavir and afatinib on second treatment day

DRUG

ritonavir + afatinib

on the second treatment day the first ritonavir tablet will be taken 6 hours after the afatinib tablet

Trial Locations (1)

1200.151.1 Boehringer Ingelheim Investigational Site, Biberach